Encompass Health Corporation $EHC Shares Sold by Hantz Financial Services Inc.

Hantz Financial Services Inc. lessened its holdings in Encompass Health Corporation (NYSE:EHC) by 13.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 66,242 shares of the company’s stock after selling 10,658 shares during the quarter. Hantz Financial Services Inc. owned about 0.07% of Encompass Health worth $8,414,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Citizens National Bank Trust Department acquired a new stake in shares of Encompass Health in the third quarter worth $26,000. First Horizon Corp acquired a new stake in Encompass Health during the 3rd quarter worth about $34,000. Westside Investment Management Inc. raised its stake in shares of Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after buying an additional 101 shares during the last quarter. Root Financial Partners LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at about $39,000. Finally, Newbridge Financial Services Group Inc. boosted its stake in shares of Encompass Health by 112.5% in the second quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock worth $52,000 after buying an additional 225 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Barclays lifted their price target on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Finally, Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $142.86.

Encompass Health Stock Performance

EHC opened at $95.64 on Thursday. The firm’s fifty day simple moving average is $104.81 and its two-hundred day simple moving average is $114.55. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The company has a market cap of $9.62 billion, a price-to-earnings ratio of 18.08, a PEG ratio of 1.52 and a beta of 0.73. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.